RavenQuest BioMed Inc.

RVVQF

CA7543871080

Business Support Services

Market Closed - OTC Markets Other stock markets 02:04:35 2024-04-26 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2020	RavenQuest BioMed Inc. announced that it has received CAD 0.480718 million in funding	CI
2020	RavenQuest BioMed Inc. announced that it expects to receive CAD 1 million in funding	CI

Ravenquest Biomed Inc. Reports Earnings Results for the Full Year Ended October 31, 2018

March 28, 2019 at 06:09 pm EST

Ravenquest Biomed Inc. announced earnings results for the full year ended October 31, 2018. For the full year, the company announced sales was CAD 1.256 million compared to CAD 112,351 a year ago. Net loss was CAD 30.467 million compared to CAD 3.301 million a year ago. Basic loss per share was CAD 0.33 compared to CAD 0.1 a year ago.

Latest news about RavenQuest BioMed Inc.

RavenQuest BioMed Inc. announced that it has received CAD 0.480718 million in funding	20-03-11	CI
RavenQuest BioMed Inc. announced that it expects to receive CAD 1 million in funding	20-01-16	CI
RavenQuest BioMed Inc. completed the acquisition of Digigro Software Inc.	20-01-14	CI
RavenQuest BioMed Inc. entered into a definitive agreement to acquire Digigro Software Inc. for CAD 4.6 million.	20-01-09	CI
Ravenquest Biomed Inc. cancelled the acquisition of 51% stake in 1 Life Cannabis Corporation.	20-01-02	CI
RavenQuest BioMed Inc. Announces Change to Board of Directors	19-11-29	CI
RavenQuest BioMed Inc. Announces Management Changes	19-11-27	CI
RavenQuest BioMed Inc. Completes First Cannabis Shipment to Australia	19-11-12	CI
RavenQuest Biomed Inc. Announces Board Changes	19-11-01	CI
Ravenquest Biomed Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2019	19-09-30	CI
RavenQuest BioMed Inc. Partner McGill University Secures Cannabis License	19-09-26	CI
RavenQuest BioMed Inc. Enters Cannabis Beverage Joint Venture with the - Not-So-Gentle Tea Company	19-09-16	CI
RavenQuest BioMed Inc. Signs European Joint Venture with Cannabis Biocare	19-09-03	CI
RavenQuest BioMed Inc. announced that it has received CAD 2.5235 million in funding	19-07-18	CI
RavenQuest BioMed Inc. announced a financing transaction	19-06-27	CI
Ravenquest Biomed Inc. cancelled the acquisition of 51% stake in 1090252 B.C. Ltd.	19-06-13	CI
RavenQuest BioMed Inc. Signs Heads of Agreement with Norway's Cannabis Biocare A/S to Enter into A Joint Venture	19-05-22	CI
Ravenquest Awards Its First Cannabis Sales License from Health Canada	19-05-03	CI
Ravenquest Biomed Inc. Announces the Completion of First Shipment of Bulk Cannabis to Wayland Group	19-04-15	CI
RavenQuest BioMed Inc. Provides Update on Recent License and Production Capacity Expansion	19-04-10	CI
RavenQuest BioMed Inc. Secures Health Canada Cultivation License At Edmonton Facility	19-04-05	CI
RavenQuest BioMed Inc. cancelled the acquisition of Western AgriPharma Limited.	19-04-02	CI
Ravenquest Biomed Inc. Reports Earnings Results for the First Quarter Ended January 31, 2019	19-03-31	CI
RavenQuest BioMed Inc. announced that it has received CAD 2.213899 million in funding	19-03-28	CI
RavenQuest BioMed Inc. announced that it expects to receive CAD 3 million in funding	19-03-06	CI

Chart RavenQuest BioMed Inc.

Duration

Period

More charts

Company Profile

Ravenquest Biomed Inc is a Canada-based diversified cannabis company. The Company is focused upon cannabis production, management services and consulting and specialized research & development. The Company integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions. It provides variety of services, such as Consulting, comprehensive cannabis consulting services; Training Solutions, training of operators, engineers, architects and installers; Solutions Implementation, project management, ongoing support; Design Studio Demonstration and training facility.

Sector

Business Support Services

More about the company

Sector Management Consulting Services

	1st Jan change	Capi.
RAVENQUEST BIOMED INC.	-.--%	182
FTI CONSULTING, INC.	+12.03%	7.83B
BAYCURRENT CONSULTING, INC.	-31.15%	3.36B
ICF INTERNATIONAL, INC.	+11.72%	2.81B
NIHON M&A CENTER HOLDINGS INC.	-1.14%	1.58B
SHANGHAI RESEARCH INSTITUTE OF BUILDING SCIENCES GROUP CO., LTD.	-7.81%	1.11B
ANHUI TRANSPORT CONSULTING & DESIGN INSTITUTE CO.,LTD.	+23.03%	851M
FUNAI SOKEN HOLDINGS INCORPORATED	-10.02%	703M
THE HACKETT GROUP, INC.	-5.40%	595M
DARK HORSE TECHNOLOGY GROUP CO., LTD.	-11.91%	586M

Management Consulting Services